Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs

Japanese Journal of Antibiotics

Volumn 52, Issue 4, 1999, Pages 310-311

  Inoue, Matsuhisa ^a   Saito, Akira ^b   Shimizu, Yoshinori ^c   Watanabe, Akira ^d   Kawai, Tadashi ^e   Hayashi, Mutsumu ^f   Kanno, Harushige ^g   Kubo, Setsuko ^h   Ubukata, Kimiko ^h   Igari, Jun ⁱ   Oguri, Toyoko ^j   Kobayashi, Yoshio ^a   Shiba, Kouya ^b   Sakamoto, Mitsuo ^c   Tokue, Yutaka ^d   Yamaguchi, Keizo ^e   Miyazaki, Shuichi ^f   Inamatsu, Takashi ^g   Shimada, Jingoro ^h   Kaku, Mitsuo ^h   Kuga, Akio ⁱ   Ichiyama, Satoshi ^j   Aihara, Masanori ^a   Higashitsutsumi, Minoru ^b   Sakamoto, Masako ^c   Kohno, Shigeru ^d   Tomono, Kazunori ^e   Hlrakata, Yoichi ^f   Saito, Atsushi ^g   Kusano, Nobuchika ^h   Ueda, Yasushi ^h   more..

^a KITASATO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Department of Laboratory Medicine   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h JUNTENDO UNIVERSITY   (Japan)

ⁱ KEIO UNIVERSITY   (Japan)

^j JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS GALLINARUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; HUMANS; METHICILLIN RESISTANCE; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN; VIRGINIAMYCIN;

EID: 0032890645     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. UTTLEY, A. H. C.; C. H. COLLINS, J. NAIDOO, et al.: Vancomycin-resistant enterococci. Lancet 2/9: 57-58, 1988
2. LECLERCQ, R.; E. DERLOT, J. DUVAL, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococciisfaeciwn. N. Engl. J. Med. 319: 157-161, 1988
3. UTTLLY, A. H. C.; R. C. GEORGE, J. NAIDOO, et al.: Highlevel vancomycin-resistant enterococci causing hospital infections. Epidemiol. Infect. 103: 173-181, 1989
4. HANDWERGER, S.; D. C. PERLMAN, D. ALTARAC, et al.: Concomitant high-level vancomycin and penicillin resistance in clinical isolates of Enterococci. Clin. Infect. Dis. 14: 655-661, 1992
5. Nosocomial enterococci resistant to vancomycin-United States 1989-1993. MMWR42: 597-599, 1993
6. MONTERCALVO, M A.; H. HOROWITZ, C. GEDRIS, et al.: Outbreak of vancomycin-, ampicillin-, and aminoglycosideresistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob. Agents Chemother. 38: 1363-1367, 1994
7. APPELBAUM, P. C.; S. K. SPANGLER & M. R. JACOBS: Susceptibility of 539 Gram-positive and Gram-negative anaerobes to new agents, including RP59500, biapenem, trospcctomycin and piperacillin/tazobactam. J. Antimicrob. Chemother. 32: 223-231, 1993
8. BRUMFITT, W.; J. M. T. HAMILTON-MILLER & S. SHAH: Invitro activity of RP59500, a new semisynthetic streptogramin antibiotic, against Gram-positive bacteria. J. Antimictob. Chemother. 30: 29-37, 1992
9. DUBOIS, J. & J. R. JOLY: ln-vitro activity of RP59500, a new synergic antibacterial agent, against Legionella spp. J. Antimcrob. Chemother. 30: 77-81, 1992
10. INOUE, M.; R. OKAMOTO, T. OKUBO, et al.: Comparative in-vitro activity of RP59500 against clinical bacterial isolates. J. Antimicrob. Chemother. 30: 45-51, 1992
11. VERBIST, L & J. VERIIAEGEN: Comparative in-vitro activity of RP59500. J. Antimicrob. Chemother. 30: 39-44, 1992
12. JOHNSON C. C.; L. SLAVOSKI, M. SCIIWARTZ, et al.: In vitro activity of RP59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumonias and Enterococci. Diagn. Microbiol. Infect. Dis. 21: 169-173, 1995
13. MALEN, S. D.; E. STEFAN & C. PATRICE: Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant Enterococci by PCR. J. Clin. Microbiol. 33:24-27,1995
14. SCHABERG, D. R.; D. H. CULVER & R. P. GAYNES: Major trends in the microbial etiology of nosocominal infections. Am. J. Med. 91: 72-75, 1990
15. GOTO, S.; S. MIYAZAKI & Y. KANEKO: The in-vitro activity of RP59500 against Gram-positive cocci. J. Antimicrob. Chemotherapy. 30: 25-28, 1992
16. ISHII, Y.; A. OIINO, S. KASIIITANI, et al.: Identification of VanB-type vancomycin resistance I. Enterococcus gallinarum from Japan. J. Infect. Chemother. 2: 102-105, 1996
17. AARESTRUP, F. M.: Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microbial Drug Resistance 1:255-257, 1995
18. NOBLE, W. C.; V. ZARINA & G. A. C. ROSEMARY: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphyhcocctis aureus. FEMS Microbiol Letters. 93: 195-198,1992